State Street Corporation 13D and 13G filings for PMV Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-23 09:07 am Purchase |
2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
STATE STREET CORP STT |
723,454 1.410% |
76,904 (+11.89%) |
Filing |
| 2023-05-10 09:19 am Sale |
2023-04-30 | 13G | PMV Pharmaceuticals, Inc. PMVP |
STATE STREET CORP STT |
646,550 1.410% |
-2,660,686 (-80.45%) |
Filing |
| 2023-02-10 11:26 am Sale |
2022-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
STATE STREET CORP STT |
3,307,236 7.240% |
-1,864,254 (-36.05%) |
Filing |
| 2022-07-11 1:28 pm Purchase |
2022-06-30 | 13G | PMV Pharmaceuticals, Inc. PMVP |
STATE STREET CORP STT |
5,171,490 11.350% |
5,171,490 (New Position) |
Filing |